Relative Bioavailability of Iron and Folic Acid in New Test Supplement

Inclusion Criteria: * Healthy pregnant women between 18 and 45 years of age in the second or third trimester of pregnancy (24-32 weeks of gestational age). * Normal Hb (Hb≥110g/L and Hb≤144g/L) Exclusion Criteria: Chronic illness (clinically significant neurological, endocrine, cardiovascular, pulmonary, hematologic, immunologic, psychiatric or metabolic diseases) * A history or presence of hemosiderosis, hemochromatosis, peptic ulcer, regional enteritis, ulcerative colitis * A history of or current use of IV iron therapy or erythropoietin therapy * A history or presence of any clinically significant gastrointestinal pathology (eg. chronic diarrhea, inflammatory bowel disease, partial gastrectomy), unresolved gastrointestinal symptoms (eg. diarrhea or vomiting), steatorrhea, or other conditions known to interfere with the absorption, distribution, metabolism or excretion of iron or folic acid * Abnormal hemoglobin electrophoresis ie. sickle cell anemia, thalassemia, etc. * Current acute illness and/or taking antibiotics * Known or suspected allergies to Materna®, or any ingredient present in Materna or SuppleFem Sprinkles or any of the foods to be consumed during the trial. * Mildly to severely anemic women (Hb\<110 g/L) or elevated hemoglobin (above 144g/L) * Complications in pregnancy (including pregnancy induced hypertension, preeclampsia, a history of severe antepartum hemorrhage) * Blood transfusion within last 3 months